First Aid Shot Therapy rakes in $24 mln Series C

Burlingame, California-based First Aid Shot Therapy, a developer of over-the-counter medicine in liquid shot form, has raised $24 million in Series C funding. Johnson & Johnson Innovation – JJDC Inc led the round with participation from other investors that included Lumira Capital, Sofinnova Ventures, Redmile Group and HealthQuest Capital.

North AmericaUSBriefs